AptarGroup CAO Gandhi to resign Sept. 2026

AptarGroup’s chief accounting officer will resign September 11, 2026, with former CAO Daniel Ackerman returning as interim principal accounting officer.

Rhea-AI Filing Summary

APTARGROUP, INC. (ATR) reported that Aditya J. Gandhi, Vice President, Chief Accounting Officer and principal accounting officer, has decided to resign effective September 11, 2026 to pursue another opportunity outside the greater Chicago area. The company states his resignation is not due to any disagreement regarding operations, policies or practices.

Effective as of the separation date, the Board appointed Daniel Ackerman

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Separation Date: September 11, 2026 Appointment Date: September 11, 2026 Age of Daniel Ackerman: 53 +2 more

5 metrics

Separation Date September 11, 2026 Effective date of Aditya J. Gandhi’s resignation as Chief Accounting Officer

Appointment Date September 11, 2026 Effective date of Daniel Ackerman’s appointment as Senior Vice President, Interim Chief Accounting Officer

Age of Daniel Ackerman 53 Age of the newly appointed Senior Vice President, Interim Chief Accounting Officer

Prior CAO tenure of Daniel Ackerman August 1, 2024 to June 8, 2026 Period when Ackerman previously served as Chief Accounting Officer and principal accounting officer

Current finance role start June 2026 Month and year when Ackerman began serving as Senior Vice President, Finance for Aptar Pharma

Key Terms

principal accounting officer, Item 404(a) of Regulation S-K, emerging growth company

3 terms

principal accounting officer financial

"will serve as the Company’s principal accounting officer and will report"

The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.

Item 404(a) of Regulation S-K regulatory

"any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K"

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did AptarGroup (ATR) announce the resignation of its Chief Accounting Officer?

AptarGroup disclosed that Aditya J. Gandhi, its Vice President, Chief Accounting Officer and principal accounting officer, will resign effective September 11, 2026 to pursue another opportunity outside the greater Chicago area. The company states his decision was not due to any disagreement on operations, policies or practices.

Who will serve as interim Chief Accounting Officer at AptarGroup (ATR)?

The Board appointed Daniel Ackerman as Senior Vice President, Interim Chief Accounting Officer, effective as of the September 11, 2026 separation date. He will also serve as principal accounting officer and report to Vanessa Kanu, Executive Vice President and Chief Financial Officer.

What is Daniel Ackerman’s prior experience at AptarGroup (ATR)?

Daniel Ackerman previously served as AptarGroup’s Chief Accounting Officer and principal accounting officer from August 1, 2024 until June 8, 2026. He has served as Senior Vice President, Finance for Aptar Pharma since June 2026 and originally joined the company in 2015 as Vice President, Corporate Controller.

Did AptarGroup (ATR) report any disagreement with Aditya J. Gandhi related to his resignation?

No. AptarGroup states that Mr. Gandhi’s decision to resign was not the result of any disagreement with the company on any matter relating to its operations, policies or practices.

Are there any related-party or family relationships tied to Daniel Ackerman’s appointment at AptarGroup (ATR)?

The company states there are no arrangements or understandings with other persons regarding Mr. Ackerman’s appointment, no family relationships between him and any director or executive officer, and he has no interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:06 PM Accepted by SEC EDGAR 09/10/2026 - 04:06 PM Learn about SEC filing dates

false 0000896622 0000896622 2026-09-04 2026-09-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

September 4, 2026

Date of Report (Date of earliest event reported)

AptarGroup, Inc.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation) 1-11846
(Commission File Number) 36-3853103
(IRS Employer Identification No.)

265 Exchange Drive, Suite 301, Crystal Lake, Illinois 60014

(Address of principal executive offices)

Registrant’s telephone number, including area code: 815-477-0424

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	ATR	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 4, 2026, Aditya J. Gandhi, Vice President, Chief Accounting Officer of AptarGroup, Inc. (the “Company”), notified the Company of his decision to resign from his positions as Vice President, Chief Accounting Officer and principal accounting officer of the Company, effective on September 11, 2026 (the “Separation Date”). Mr. Gandhi is resigning to pursue another opportunity outside the greater Chicago area. Mr. Gandhi’s decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

On September 10, 2026, the Board of Directors of the Company (the “Board”) appointed Daniel Ackerman as the Company’s Senior Vice President, Interim Chief Accounting Officer, effective as of the Separation Date. Mr. Ackerman, age 53, who was the Company’s Chief Accounting Officer and principal accounting officer from August 1, 2024 until June 8, 2026, when Mr. Gandhi assumed the position, will resume the role until the appointment of a permanent successor. In this role, Mr. Ackerman will serve as the Company’s principal accounting officer and will report to Vanessa Kanu, Executive Vice President and Chief Financial Officer. Mr. Ackerman has served as Senior Vice President, Finance for Aptar Pharma since June 2026. Mr. Ackerman joined the Company in 2015 as Vice President, Corporate Controller.

There are no arrangements or understandings between Mr. Ackerman and any other persons pursuant to which Mr. Ackerman was appointed as Senior Vice President, Interim Chief Accounting Officer of the Company. There are no family relationships between Mr. Ackerman and any director or executive officer of the Company, and he has no direct or indirect interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AptarGroup, Inc.
Date: September 10, 2026	By:	/s/ Irene Hudson
		Irene Hudson
		Executive Vice President, Chief Legal Officer and Secretary

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 33.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 21.8 KB